Literature DB >> 1708855

Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions.

M Dierssen1, J Flórez, M A Hurlé.   

Abstract

The study was aimed at elucidating the possible participation of L-type Ca2+ channel in the acute analgesic effect of an opiate and the development of tolerance to this action. Sufentanil, a selective mu agonist, and two dihydropyridines, the Ca2+ antagonist nimodipine and the Ca2+ agonist Bay K 8644, were selected. The tailflick test was used to assess the nociceptive threshold. In naive rats, nimodipine (200 micrograms/kg) potentiated the analgesic effect of sufentanil reducing the ED50 from 0.26 to 0.08 microgram/kg. Similar results were observed with its (-)-enantiomer Bay N 5248, while the (+) enantiomer Bay N 5247 was ineffective. Tolerance to the opiate was induced by chronic subcutaneous administration of sufentanil with minipumps (2 micrograms/h, 7 days). In these conditions the dose-response curve to sufentanil was displaced to the right and the ED50 was increased to 1.49 micrograms/kg. In tolerant rats, nimodipine preserved its potentiating ability and prevented the displacement to the right of the sufentanil dose response-curve (ED50 = 0.48 microgram/kg). When nimodipine was pumped (1 microgram/h, 7 days) concurrently with sufentanil, the development of tolerance to the opioid was not disturbed. However, the expression of tolerance was abolished and even the effect of acutely administered sufentanil was markedly potentiated (ED50 = 0.03 microgram/kg). Similar experiments were performed with Bay K 8644. In naive rats, Bay K 8644 at a low dose (20 micrograms/kg) that behaves as a calcium agonist, antagonized the analgesic effect of sufentanil (ED50 = 0.58 microgram/kg), whereas at a high dose (200 micrograms/kg) it potentiated this action (ED50 = 0.15 microgram/kg).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708855     DOI: 10.1007/bf00169046

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

1.  Chronic morphine administration and in vivo pertussis toxin treatment induce hyperalgesia and enhance 3H-nitrendipine binding.

Authors:  R Inoki; T Ohnishi; K Saito; S Maeda; K Matsumoto; M Sakuda
Journal:  Prog Clin Biol Res       Date:  1990

2.  Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance.

Authors:  R A Harris; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

Review 3.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

Review 4.  Metal ion interactions with opiates.

Authors:  D B Chapman; E L Way
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

5.  Effects of acute and chronic morphine treatments on calcium localization and binding in brain.

Authors:  H Yamamoto; R A Harris; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

6.  Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists.

Authors:  G Benedek; M Szikszay
Journal:  Pharmacol Res Commun       Date:  1984-10

7.  Opioid peptides selective for mu- and delta-opiate receptors reduce calcium-dependent action potential duration by increasing potassium conductance.

Authors:  M A Werz; R L MacDonald
Journal:  Neurosci Lett       Date:  1983-12-02       Impact factor: 3.046

8.  The effect of kappa agonist U50-488H on [3H]nimodipine receptor binding in rat brain regions.

Authors:  V C Gandhi; D H Ross
Journal:  Eur J Pharmacol       Date:  1988-05-20       Impact factor: 4.432

9.  Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence.

Authors:  V Ramkumar; E E el-Fakahany
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

10.  Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance.

Authors:  E Contreras; L Tamayo; M Amigo
Journal:  Eur J Pharmacol       Date:  1988-04-13       Impact factor: 4.432

View more
  8 in total

1.  Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil.

Authors:  M A Hurlé; I Goirigolzarri; E M Valdizán
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Increased opioid dependence in a mouse model of panic disorder.

Authors:  Xavier Gallego; Patricia Murtra; Teresa Zamalloa; Josep Maria Canals; Joseba Pineda; Alejandro Amador-Arjona; Rafael Maldonado; Mara Dierssen
Journal:  Front Behav Neurosci       Date:  2010-02-22       Impact factor: 3.558

3.  Enhanced analgesic effect of morphine-nimodipine combination after intraspinal administration as compared to systemic administration in mice.

Authors:  Dilip Verma; Subrata Basu Ray; Ishan Patro; Shashi Wadhwa
Journal:  J Biosci       Date:  2005-09       Impact factor: 1.826

4.  Antinociceptive effect of a novel armed spider peptide Tx3-5 in pathological pain models in mice.

Authors:  Sara M Oliveira; Cássia R Silva; Gabriela Trevisan; Jardel G Villarinho; Marta N Cordeiro; Michael Richardson; Márcia H Borges; Célio J Castro; Marcus V Gomez; Juliano Ferreira
Journal:  Pflugers Arch       Date:  2016-02-22       Impact factor: 3.657

5.  Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats.

Authors:  A Zharkovsky; A M Tötterman; J Moisio; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

6.  L-type calcium channel blockers, morphine and pain: Newer insights.

Authors:  Rakesh Kumar; Rd Mehra; S Basu Ray
Journal:  Indian J Anaesth       Date:  2010-03

7.  Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.

Authors:  J V Garaulet; M L Laorden; M V Milanés
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

8.  Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats.

Authors:  F Ruiz; M Dierssen; J Flórez; M A Hurlé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.